Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993

Inflammatory Bowel Diseases

Volumn 14, Issue 7, 2008, Pages 984-991

  Aamodt, Geir ^a,b   Johnsen, Jørgen ^c   Bengtson, May Bente ^d   Moum, Bjoørn ^c   Vatn, Morten H ^a,e  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d Medical Departments   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Crohn's disease; Ecological analysis; Spatial clustering; Spatial scan statistics; Ulcerative colitis

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; ECOLOGY; EDUCATIONAL STATUS; ENTERITIS; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NORWAY; POISSON DISTRIBUTION; PRIORITY JOURNAL; RURAL AREA; SOCIOECONOMICS; URBAN AREA;

CLUSTER ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; NORWAY; SOCIOECONOMIC FACTORS; URBANIZATION;

EID: 47949119316     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20417     Document Type: Article

References (37)

1. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001; 345:340-350.
2. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007;132:1359-1374.
3. Bernklev T, Jahnsen J, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 2005;11:909-918.
4. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease - "colitis indeterminate." J Clin Pathol. 1978;31:567-577.
5. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
6. Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93 - a prospective population-based study. Scand J Gastroenterol. 1996;31:355-361.
7. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93 - A prospective population-based study. Scand J Gastroenterol. 1996; 31:362-366.
8. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1-20.
9. Hugot JP. Genetic origin of IBD. Inflamm Bowel Dis. 2004;10:S11-S15.
10. Hugot JP. Inflammatory bowel disease: a complex group of genetic disorders. Best Pract Res Clin Gastroenterol. 2004;18:451-462.
11. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
12. Henriksen M, Jahnsen J, Lygren I, et al. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006;41:1037-1043.
13. Kulldorff M. SaTScan [www satscan org web site]. 2004.
14. Kulldorff M. A spatial scan statistics. Commun Stat Theory Methods. 1997;26:1481-1496.
15. Besag JE, York JC, Mollie A. Bayesian image restoration with two applications in spatial statistics (with discussion). Ann Inst Stat Math. 1991;43:1-59.
16. Statistical Yearbook of Oslo 2006. Municipality of Oslo; 2007.
17. Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology. 2004;127:1051-1057.
18. Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis. 2006;12:218-226.
19. Green C, Elliott L, Beaudoin C, et al. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol. 2006;164:615-623.
20. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531.
21. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559-1568.
22. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J of Epidemiol. 2001;154:328-335.
23. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006;12:212-217.
24. Aamodt G, Samuelsen SO, Skrondal A. A simulation study of three methods for detecting disease clusters. Int J Health Geogr. 2006;5:15.
25. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004;3:394-400.
26. Sanderson JD, Moss MT, Tizard ML, et al. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut. 1992;33:890-896.
27. Singh UP, Singh S, Singh R, et al. Influence of Mycobacterium avium paratuberculosis on colitis development and specific immune responses during disease. Infect Immun. 2007;75:3722-3728.
28. Chen W, Li D, Paulus B, et al. Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J Gastroenterol Hepatol. 2000;15:1145-1150.
29. Ponsioen CY, Defoer J, Ten Kate FJ, et al. A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur J Gastroenterol Hepatol. 2002;14:641-648.
30. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:669-675.
31. Criscuoli V, Rizzuto MR, Cottone M. Cytomegalovirus and inflammatory bowel disease: is there a link? World J Gastroenterol. 2006;12: 4813-4818.
32. Mallant-Hent RC, Mooij M, von Blomberg BM, et al. Correlation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBD. World J Gastroenterol. 2006;12:292-297.
33. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47:861-869.
34. Ladd CO, Huot RL, Thrivikraman KV, et al. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res. 2000;122:81-103.
35. Delaney JC, Smeester L, Wong CY, et al. AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo. Nat Struct Mol Biol. 2005;12:855-860.
36. Perl DP, Fogarty U, Harpaz N, et al. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis. 2004;10:881-883.
37. Banks D, Frengstad B, Midtgard AK, et al. The chemistry of Norwegian groundwaters: I. The distribution of radon, major and minor elements in 1604 crystalline bedrock groundwaters. Sci Total Environ. 1998;222: 71-91.